CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

Parkinson’s disease (PD) affects millions of patients worldwide and is characterized by alpha-synuclein aggregation in dopamine neurons. Molecular tweezers have shown high potential as anti-aggregation agents targeting positively charged residues of proteins undergoing amyloidogenic processes. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Bengoa-Vergniory, Nora, Faggiani, Emilie, Ramos-Gonzalez, Paula, Kirkiz, Ecem, Connor-Robson, Natalie, Brown, Liam V., Siddique, Ibrar, Li, Zizheng, Vingill, Siv, Cioroch, Milena, Cavaliere, Fabio, Threlfell, Sarah, Roberts, Bradley, Schrader, Thomas, Klärner, Frank-Gerrit, Cragg, Stephanie, Dehay, Benjamin, Bitan, Gal, Matute, Carlos, Bezard, Erwan, Wade-Martins, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522721/
https://www.ncbi.nlm.nih.gov/pubmed/32985503
http://dx.doi.org/10.1038/s41467-020-18689-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522721/
https://www.ncbi.nlm.nih.gov/pubmed/32985503
http://dx.doi.org/10.1038/s41467-020-18689-x

Ejemplares similares